<--- Back to Details
First PageDocument Content
Stem cells / Hematology / Cell biology / Myeloid leukemia / Myelodysplastic syndrome / Syndromes / Acute myeloid leukemia / Myeloperoxidase / International Prognostic Scoring System / Biology / Medicine / Oncology
Date: 2011-01-19 12:37:03
Stem cells
Hematology
Cell biology
Myeloid leukemia
Myelodysplastic syndrome
Syndromes
Acute myeloid leukemia
Myeloperoxidase
International Prognostic Scoring System
Biology
Medicine
Oncology

GLAL_A_375719 ++

Add to Reading List

Source URL: en.actc-lab.chem.uoa.gr

Download Document from Source Website

File Size: 696,98 KB

Share Document on Facebook

Similar Documents

GLAL_A_375719 ++

GLAL_A_375719 ++

DocID: 19fUF - View Document

PBAC STAKEHOLDER MEETING OUTCOME STATEMENT RUXOLITINIB FOR MYELOFIBROSIS 22 September 2014 The Sheraton Hotel, Melbourne Attendees Members of the Pharmaceutical Benefits Advisory Committee (PBAC), the consumer

PBAC STAKEHOLDER MEETING OUTCOME STATEMENT RUXOLITINIB FOR MYELOFIBROSIS 22 September 2014 The Sheraton Hotel, Melbourne Attendees Members of the Pharmaceutical Benefits Advisory Committee (PBAC), the consumer

DocID: 103lx - View Document

Pharmaceutical Benefits Scheme / Pharmacology / Myelofibrosis / International Prognostic Scoring System / IPSS / Clinical trial / Medicine / Health / Ruxolitinib

PBAC STAKEHOLDER MEETING OUTCOME STATEMENT RUXOLITINIB FOR MYELOFIBROSIS 22 September 2014 The Sheraton Hotel, Melbourne Attendees Members of the Pharmaceutical Benefits Advisory Committee (PBAC), the consumer representa

DocID: ZuUz - View Document

Microsoft PowerPoint - LLS1104 - MDS slides - on background v14 (for pdf) [Compatibility Mode]

Microsoft PowerPoint - LLS1104 - MDS slides - on background v14 (for pdf) [Compatibility Mode]

DocID: YwaP - View Document

Table 16.1  The World Health Organization[removed]classification of myelodysplasia.  Subtype Peripheral blood

Table 16.1  The World Health Organization[removed]classification of myelodysplasia. Subtype Peripheral blood

DocID: XbLN - View Document